Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
Few patients with neurodegenerative disorders require spinal surgery.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Differential microRNA expression in blood in multiple sclerosis.
Quetiapine Fumarate for the Treatment of Multiple Sclerosis: Focus on Myelin Repair.
Erratum to "Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics"
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
Pregnancy and multiple sclerosis.
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
Comparison of LC-UV and LC-MS methods for simultaneous determination of teriflunomide, dimethyl fumarate and fampridine in human plasma, application to rat PK study.
Concurrent acute disseminated encephalomyelitis and Guillain-Barré syndrome in a child.
Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up.
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey.
11C-Acetate PET Imaging in Patients with Multiple Sclerosis.
Profile of Differential Promoter Activity by Nucleotide Substitution at GWAS Signals For Multiple Sclerosis.
Statins and Neuroprotection: Basic Pharmacology Needed.
[Ultrahigh field MRI in context of neurological diseases.]
Disability in multiple sclerosis: When synaptic long-term potentiation fails.
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.

Pages